Synthesis and structural studies of the simplest bismuth(iii) oxo-salicylate complex: [Bi4(μ3-O)2(HO-2-C6H4CO2)8]·2Solv (Solv = MeCN or MeNO2)

Structure of the active pharmaceutical ingredient bismuth subsalicylate

Structure determination of pharmaceutical compounds is invaluable for drug development but remains challenging for those that form as small crystals with defects. Bismuth subsalicylate, among the most commercially significant bismuth compounds, is an active ingredient in over-the-counter medications such as Pepto-Bismol, used to treat dyspepsia and H. pylori infections. Despite its century-long history, the structure of bismuth subsalicylate is still under debate. Here we show that advanced electron microscopy techniques, namely three-dimensional electron diffraction and scanning transmission electron microscopy, can give insight into the structure of active pharmaceutical ingredients that are difficult to characterize using conventional methods due to their small size or intricate structural features. Hierarchical clustering analysis of three-dimensional electron diffraction data from ordered crystals of bismuth subsalicylate revealed a layered structure. A detailed investigation using high-resolution scanning transmission electron microscopy showed variations in the stacking of layers, the presence of which has likely hindered structure solution by other means. Together, these modern electron crystallography techniques provide a toolbox for structure determination of active pharmaceutical ingredients and drug discovery, demonstrated by this study of bismuth subsalicylate.

Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging

The poor retention and survival of cells after transplantation to solid tissue represent a major obstacle for the effectiveness of stem cell-based therapies. The ability to track stem cells in vivo can lead to a better understanding of the biodistribution of transplanted cells, in addition to improving the analysis of stem cell therapies' outcomes. Here, we described the use of a carbon nanotube-based contrast agent (CA) for X-ray computed tomography (CT) imaging as an intracellular CA to label bone marrow-derived mesenchymal stem cells (MSCs). Porcine MSCs were labeled without observed cytotoxicity. The CA consists of a hybrid material containing ultra-short single-walled carbon nanotubes (20-80 nm in length, US-tubes) and Bi(III) oxo-salicylate clusters which contain four Bi³⁺ ions per cluster (Bi₄C). The CA is thus abbreviated as Bi₄C@US-tubes.

Heteroaryl bismuthines: a novel synthetic concept and metalπ heteroarene interactions

The alkoxide Bi[OCMe₂(2-C₄H₃S)]₃ (1) is formed by the reaction of three equiv. of the alcohol HOCMe₂(2-C₄H₃S) with Bi(O^tBu)₃ and subsequent hydrolysis provides the bismuth oxido cluster [Bi₄O₂{OCMe₂(2-C₄H₃S)}₈] (2). In contrast, the reaction of Bi(O^tBu)₃ and Bi[N(SiMe₃)₂]₃ with the silanols HOSiMe₂(2-C₄H₃X) (X = O, S, Se, and NMe), HOSiMe₂(2-C₄H₂S-5-SiMe₃) and HOSiMe₂(3-C₄H₃S) leads to the formation of tris(heteroaryl)bismuthines Bi(2-C₄H₂X-5-R)₃ [where X = O, R = H (3); X = S, R = H (4); X = S, R = SiMe₃ (5); X = NMe, R = H (6); X = Se, R = H (7)] and Bi(3-C₄H₃S)₃ (8). For the silanols, bismuth-carbon bond formation is observed rather than silanol-alcoholate or silanol-amide exchange. The structures of compounds 1, 2, and 4-7a in the solid state were established by single crystal X-ray diffraction and all compounds except 5 show London dispersion type bismuthπ heteroarene interactions. For the bismuthine Bi(2-C₄H₃Se)₃ (7), two polymorphs were isolated depending on the conditions of crystallization. At 8 °C, polymorph I (7a) crystallizes from an n-hexane solution in the triclinic space group P1[combining macron], whereas polymorph II (7b) crystallizes at 20 °C from a CH₂Cl₂/n-pentane solution in the monoclinic space group P2₁/c. The heteroaryl bismuthines 3 and 4 exhibit 2D network structures as a result of bismuthπ heteroarene interactions, whereas for the pyrrole derivative 6 the dispersion type interactions provide separated dimers.

Creation of bismuth-tungsten oxide nanoclusters using lacunary polyoxometalates

Three types of heterometallic bismuth-tungsten oxide nanoclusters were successfully synthesized by the reactions of lacunary silicotungstates (trivacant [A-α-SiW₉O₃₄]^10- and divacant [γ-SiW₁₀O₃₆]^8-) and Bi³⁺ in organic solvents. Lone pairs on Bi³⁺ acted as structure-directing groups in these nanoclusters.

High-Performance Hybrid Bismuth-Carbon Nanotube Based Contrast Agent for X-ray CT Imaging

Carbon nanotubes (CNTs) have been used for a plethora of biomedical applications, including their use as delivery vehicles for drugs, imaging agents, proteins, DNA, and other materials. Here, we describe the synthesis and characterization of a new CNT-based contrast agent (CA) for X-ray computed tomography (CT) imaging. The CA is a hybrid material derived from ultrashort single-walled carbon nanotubes (20-80 nm long, US-tubes) and Bi(III) oxo-salicylate clusters with four Bi(III) ions per cluster (Bi₄C). The element bismuth was chosen over iodine, which is the conventional element used for CT CAs in the clinic today due to its high X-ray attenuation capability and its low toxicity, which makes bismuth a more-promising element for new CT CA design. The new CA contains 20% by weight bismuth with no detectable release of bismuth after a 48 h challenge by various biological media at 37 °C, demonstrating the presence of a strong interaction between the two components of the hybrid material. The performance of the new Bi₄C@US-tubes solid material as a CT CA has been assessed using a clinical scanner and found to possess an X-ray attenuation ability of >2000 Hounsfield units (HU).

Anionic Bismuth-Oxido Carboxylate Clusters with Transition Metal Countercations

Six new anionic bismuth-oxido clusters containing trifluoroacetate ligands were prepared. These include two new Bi₆O₈ clusters: [M(NCMe)₂(H₂O)₄]₃[Bi₆(μ₃-O)₄(μ₃-OH)₄(CF₃CO₂)₁₂] with an octahedral Bi₆O₄(OH)₄ core (M = Ni, 1a; Co, 1b) and four Bi₄O₂ clusters, {[Co(NCMe)₆][Bi₄(μ₃-O)₂(CF₃CO₂)₁₀]}_n (2a), {[Co{HC(MeCO)₂(MeCNH)}₂][Bi₄(μ₃-O)₂(CF₃CO₂)₁₀]·2[CF₃CO₂]·2[CF₃CO₂H]·2[H₂O]}_n (2b), {[Cu(NCMe)₄]₂[Bi₄(μ₃-O)₂(CF₃CO₂)₁₀]·2[CF₃CO₂H]}_n (2c), and {[Me₄N]₂[Bi₄(μ₃-O)₂(CF₃CO₂)₁₀]·2[CF₃CO₂H]}_n (2d). These are among the first bismuth-oxido anionic clusters synthesized, and the first to have transition metal countercations. The Bi₆O₈ anion in 1a and 1b is a high-symmetry octahedron. Additionally, two of the new Bi₄O₂ clusters are arranged in 1D polymeric structures via bridging carboxylate ligands. The cation in compound 2c had not been previously characterized and was also observed in the synthesis of [Co{HC(MeCO)₂(MeCNH)}₂][Bi(NO₃)₆] (3). The new compounds were characterized using single crystal X-ray crystallography and elemental analysis.